This clinical trial is focused on understanding how the medication zolpidem works in different groups of people. The study involves patients with disorders of consciousness, individuals with vision impairments, and neurotypical volunteers, who represent the general population. Some people in these groups have unusual reactions to zolpidem, such as regaining consciousness or temporarily recovering vision. The study aims to explore these unexpected responses to improve personalized care for patients.
The trial will use two medications: zolpidem, which is a film-coated tablet, and mannitol, which is a capsule. Participants will take these medications orally, either by mouth or through a tube if necessary. The study will observe how these medications affect the participants over a short period, with a focus on understanding the unique reactions some people have to zolpidem.
Throughout the study, researchers will monitor various aspects such as consciousness levels, alertness, and cognitive performance. They will also use techniques like high-density electroencephalography (hdEEG) to study brain activity. The findings from this study could lead to better understanding and treatment options for those who experience paradoxical responses to zolpidem.



Belgium